300 related articles for article (PubMed ID: 35494210)
61. Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
Ota N; Kato K; Iwano S; Ito S; Abe S; Fujita N; Yamashiro K; Yamamoto S; Naganawa S
Br J Radiol; 2014 Feb; 87(1034):20130444. PubMed ID: 24297809
[TBL] [Abstract][Full Text] [Related]
62. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
63. [99mTc]cFLFLF for Early Diagnosis and Therapeutic Evaluation in a Rat Model of Acute Osteomyelitis.
Chen J; Cheng H; Dong Q; Chen F; Huang Z; Zhang Y; Pan D; Xiong W
Mol Imaging Biol; 2015 Jun; 17(3):337-44. PubMed ID: 25323104
[TBL] [Abstract][Full Text] [Related]
64. The role of 18F-NaF PET/CT in metastatic bone disease.
Araz M; Aras G; Küçük ÖN
J Bone Oncol; 2015 Sep; 4(3):92-7. PubMed ID: 26587375
[TBL] [Abstract][Full Text] [Related]
65. Skeletal scintigraphy as an important complement for detecting bone metastasis from nasopharyngeal carcinoma.
Yen WJ; Liu CT; Chi YM; Chang CC
J Int Med Res; 2022 Aug; 50(8):3000605221116765. PubMed ID: 36036384
[TBL] [Abstract][Full Text] [Related]
66. Head-to-head comparison of
Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
[TBL] [Abstract][Full Text] [Related]
67. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
68. Comparison of
Dadgar H; Norouzbeigi N; Jokar N; Zareizadeh J; Gholamrezanezhad A; Ahmadzadehfar H; Abbaszadeh M; Assadi M
World J Nucl Med; 2022 Mar; 21(1):1-8. PubMed ID: 35502272
[TBL] [Abstract][Full Text] [Related]
69. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables.
Qiu ZL; Wu B; Shen CT; Zhu RS; Luo QY
Ann Nucl Med; 2014 Oct; 28(8):725-35. PubMed ID: 25120244
[TBL] [Abstract][Full Text] [Related]
70. [Value of (99)Tc(m)-MDP SPECT/CT in clinical decision-making for nasopharyngeal carcinoma and a comparison of the values of different imaging techniques for diagnosing skull-base bone invasion].
Li W; Zhang RS; Zhang LQ; Lu BG; Fu WH
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):133-137. PubMed ID: 28219209
[No Abstract] [Full Text] [Related]
71. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
72. Incidental Detection of Solitary Hepatic Metastasis by 99mTc-MDP and 18F-NaF PET/CT in a Patient With Osteosarcoma of the Tibia.
Cai L; Chen Y; Huang Z; Wu J
Clin Nucl Med; 2015 Sep; 40(9):759-61. PubMed ID: 25742238
[TBL] [Abstract][Full Text] [Related]
73. The diagnostic performance of
Liu Y; Sheng J; Dong Z; Xu Y; Huang Q; Pan D; Wang L; Yang M
Clin Radiol; 2019 Mar; 74(3):196-206. PubMed ID: 30648535
[TBL] [Abstract][Full Text] [Related]
74. (18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
Komissarova M; Wong KK; Fig LM
J Nucl Med Technol; 2012 Mar; 40(1):66-7, 70. PubMed ID: 22279236
[No Abstract] [Full Text] [Related]
75. Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
Chan HP; Hu C; Yu CC; Huang TC; Peng NJ
Medicine (Baltimore); 2015 Apr; 94(13):e687. PubMed ID: 25837761
[TBL] [Abstract][Full Text] [Related]
76. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
Teke F; Teke M; Inal A; Kaplan MA; Kucukoner M; Aksu R; Urakci Z; Tasdemir B; Isikdogan A
Asian Pac J Cancer Prev; 2015; 16(1):387-91. PubMed ID: 25640386
[TBL] [Abstract][Full Text] [Related]
77. Asymmetric (99m)Tc-MDP uptake in mineralized tendons might mimic bone lesions: heterotopic tendon mineralization on a (99m)Tc-MDP bone scan and a (18)F-FDG PET/CT scan.
Chen YR; Hsieh TC; Yen KY; Shen YY; Kao CH
Clin Nucl Med; 2014 May; 39(5):480-2. PubMed ID: 23877525
[TBL] [Abstract][Full Text] [Related]
78. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
79. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
[TBL] [Abstract][Full Text] [Related]
80. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]